Published in Lancet on July 01, 2006
Lifestyle Intervention For Effective Diabetes Management (LIFE-DM) | NCT00813930
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care (2012) 21.62
Recommendations on screening for type 2 diabetes in adults. CMAJ (2012) 3.51
Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ (2010) 1.95
Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J (2010) 1.69
Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol (2012) 1.69
Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Serv Res (2008) 1.65
Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes (2013) 1.51
Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression. Stem Cell Res Ther (2015) 1.47
Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr (2017) 1.39
Association of Cardiometabolic Multimorbidity With Mortality. JAMA (2015) 1.32
Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies. BMC Endocr Disord (2014) 1.15
Universal drug coverage and socioeconomic disparities in major diabetes outcomes. Diabetes Care (2012) 1.14
TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. PLoS One (2009) 1.11
Statin use is associated with fewer periodontal lesions: A retrospective study. BMC Oral Health (2008) 1.09
Social relationships and health: is feeling positive, negative, or both (ambivalent) about your social ties related to telomeres? Health Psychol (2012) 1.08
Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines. CMAJ (2008) 1.04
Changing the way we think about endothelial cell insulin sensitivity, nitric oxide, and the pathophysiology of type 2 diabetes: the FoxO is loose. Diabetes (2013) 1.02
Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes (2012) 1.01
Daily steps are low year-round and dip lower in fall/winter: findings from a longitudinal diabetes cohort. Cardiovasc Diabetol (2010) 1.00
The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium. Diabetes (2011) 1.00
Income-related differences in mortality among people with diabetes mellitus. CMAJ (2009) 1.00
Update on the Canadian Diabetes Association 2008 clinical practice guidelines. Can Fam Physician (2009) 0.99
Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study. Cardiovasc Diabetol (2010) 0.98
Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice. Diabetes (2012) 0.97
Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus. PLoS One (2013) 0.97
Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease. Cardiovasc Diabetol (2014) 0.96
Neuropathy: the crystal ball for cardiovascular disease? Diabetes Care (2010) 0.94
Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late. Diabetes Care (2013) 0.93
American Diabetes Association indications for statins in diabetes: is there evidence? Diabetes Care (2009) 0.92
Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study. Int J Endocrinol (2014) 0.92
Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function. J Mol Cell Cardiol (2014) 0.91
Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients. Cardiovasc Diabetol (2011) 0.91
Diabetes and coronary heart disease: a risk factor for the global epidemic. Int J Hypertens (2012) 0.91
Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients. J Cancer Res Clin Oncol (2013) 0.89
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Ther Adv Musculoskelet Dis (2013) 0.89
Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia. Clin Exp Nephrol (2011) 0.88
Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res (2008) 0.88
Health utilities of type 2 diabetes-related complications: a cross-sectional study in Sweden. Int J Environ Res Public Health (2014) 0.87
Prevalence of Hypertension and Determination of Its Risk Factors in Rural Delhi. Int J Hypertens (2016) 0.87
Characterization of macro-and microvascular function and structure in patients with type 2 diabetes mellitus. Am J Cardiovasc Dis (2011) 0.86
Diabetes and cardiovascular disease. Diabetes Care (2011) 0.86
Comprehensive cardiovascular risk management--what does it mean in practice? Vasc Health Risk Manag (2007) 0.86
The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PLoS One (2014) 0.85
Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance. Diabetes Care (2010) 0.85
Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes. Diabetes Metab Syndr Obes (2011) 0.84
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation (2016) 0.84
Atherosclerosis in systemic lupus erythematosus. J Cardiovasc Pharmacol (2013) 0.83
Step Monitoring to improve ARTERial health (SMARTER) through step count prescription in type 2 diabetes and hypertension: trial design and methods. Cardiovasc Diabetol (2014) 0.83
Fructose-containing sugars and cardiovascular disease. Adv Nutr (2015) 0.82
Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis. J Am Geriatr Soc (2016) 0.82
[Diabetes and cardiovascular complications]. Wien Med Wochenschr (2010) 0.81
Cardiovascular disease, neuropathy, and retinopathy. Diabetes Care (2009) 0.81
Diabetes Mellitus, ArterialWall, and Cardiovascular Risk Assessment. Int J Environ Res Public Health (2016) 0.81
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. J Clin Invest (2017) 0.81
Sex differences in cardiovascular mortality in diabetics and nondiabetic subjects: a population-based study (Italy). Int J Endocrinol (2015) 0.80
Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study. Contemp Clin Trials (2013) 0.80
Effect of isoflurane on myocardial energetic and oxidative stress in cardiac muscle from Zucker diabetic fatty rat. J Pharmacol Exp Ther (2014) 0.78
Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease. CMAJ (2009) 0.78
DPP-4 inhibition improves early mortality, β cell function, and adipose tissue inflammation in db/db mice fed a diet containing sucrose and linoleic acid. Diabetol Metab Syndr (2016) 0.78
Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus. Vasc Health Risk Manag (2007) 0.77
Weight Loss, Dietary Intake and Pulse Wave Velocity. Pulse (Basel) (2015) 0.77
[Diabetes mellitus, coronary artery disease and heart disease]. Wien Klin Wochenschr (2016) 0.77
The Incidence of Cardiovascular Events Is Comparable Between Normoalbuminuric and Albuminuric Diabetic Patients With Chronic Kidney Disease. Medicine (Baltimore) (2016) 0.77
Impact of hypertension on various markers of subclinical atherosclerosis in early type 2 diabetes. J Diabetes Metab Disord (2014) 0.77
Potential Bioactive Compounds from Seaweed for Diabetes Management. Mar Drugs (2015) 0.77
Excess cardiovascular risk in diabetic women: a case for intensive treatment. Curr Hypertens Rep (2015) 0.77
[Thickness of carotid intima-media and cardiovascular risk factors]. Pan Afr Med J (2015) 0.76
Epidemiological aspects of heart diseases. Exp Ther Med (2016) 0.76
Oxidant status and lipid composition of erythrocyte membranes in patients with type 2 diabetes, chronic liver damage, and a combination of both pathologies. Oxid Med Cell Longev (2013) 0.76
High or low calcium intake increases cardiovascular disease risks in older patients with type 2 diabetes. Cardiovasc Diabetol (2014) 0.76
Cardiovascular disease: the other face of diabetes. CPT Pharmacometrics Syst Pharmacol (2013) 0.76
Sex Differences in the Effect of Type 2 Diabetes on Major Cardiovascular Diseases: Results from a Population-Based Study in Italy. Int J Endocrinol (2017) 0.75
Sex differences in epidemiology and risk factors of acute coronary syndrome in Chinese patients with type 2 diabetes: a long-term prospective cohort study. PLoS One (2015) 0.75
Polymorphism rs5498 of the ICAM-1 gene affects the progression of carotid atherosclerosis in patients with type 2 diabetes mellitus. Lipids Health Dis (2016) 0.75
Correlates of sitting time in adults with type 2 diabetes. BMC Public Health (2015) 0.75
Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes between General Practices. PLoS One (2016) 0.75
Estimating cardiovascular disease risk in diabetes. Lancet (2006) 0.75
Oral health and coronary heart disease. BMC Oral Health (2016) 0.75
An application of association rule mining to extract risk pattern for type 2 diabetes using tehran lipid and glucose study database. Int J Endocrinol Metab (2015) 0.75
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk. Cardiovasc Diabetol (2017) 0.75
Coronary Computed Tomography (CT) Angiography as a Predictor of Cardiac and Noncardiac Vascular Events in Asymptomatic Type 2 Diabetics: A 7-Year Population-Based Cohort Study. J Am Heart Assoc (2016) 0.75
Linagliptin as add-on therapy to insulin for patients with type 2 diabetes. Vasc Health Risk Manag (2013) 0.75
Estimating cardiovascular disease risk in diabetes. Lancet (2006) 0.75
Estimating cardiovascular disease risk in diabetes. Lancet (2006) 0.75
The role of bile acid sequestrants in the management of type 2 diabetes mellitus. Metab Syndr Relat Disord (2010) 0.75
Recommendations for management of dyslipidemia in high cardiovascular risk patients. Exp Clin Cardiol (2008) 0.75
Atherosclerotic cardiovascular disease among patients with type 2 diabetes in Basrah. World J Diabetes (2013) 0.75
Perceptions of personal health risks by medical and non-medical workers in a university medical center: a survey study. BMC Public Health (2010) 0.75
Polymorphisms of the PPAR-γ (rs1801282) and Its Coactivator (rs8192673) Have a Minor Effect on Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus. PPAR Res (2016) 0.75
Carotid atherosclerosis and its relationship to coronary heart disease and stroke risk in patients with type 2 diabetes mellitus. Medicine (Baltimore) (2017) 0.75
Gender Disparities in Lipid Goal Attainment among Type 2 Diabetes Outpatients with Coronary Heart Disease: Results from the CCMR-3B Study. Sci Rep (2017) 0.75
Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med (2006) 10.58
Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med (2004) 9.85
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA (2003) 6.39
Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA (2002) 6.30
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ (2009) 6.21
A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J (2002) 4.65
Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care (2005) 4.30
Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation (2014) 3.78
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation (2009) 3.55
Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease. J Am Coll Cardiol (2012) 3.45
Effect of socioeconomic status on treatment and mortality after stroke. Stroke (2002) 3.44
The PLAN score: a bedside prediction rule for death and severe disability following acute ischemic stroke. Arch Intern Med (2012) 3.26
Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke (2008) 3.14
Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med (2002) 3.09
Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA (2005) 3.05
Socioeconomic status and mortality after acute myocardial infarction. Ann Intern Med (2006) 3.02
Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation (2012) 2.96
Comparing hierarchical modeling with traditional logistic regression analysis among patients hospitalized with acute myocardial infarction: should we be analyzing cardiovascular outcomes data differently? Am Heart J (2003) 2.88
Deriving ethnic-specific BMI cutoff points for assessing diabetes risk. Diabetes Care (2011) 2.87
Impact of hospital nursing care on 30-day mortality for acute medical patients. J Adv Nurs (2007) 2.85
Use of fibrates in the United States and Canada. JAMA (2011) 2.82
Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation (2008) 2.76
Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol (2004) 2.69
Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA (2010) 2.61
Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation (2003) 2.61
Administrative Data Feedback for Effective Cardiac Treatment: AFFECT, a cluster randomized trial. JAMA (2005) 2.54
Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke (2013) 2.53
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation (2009) 2.40
The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med (2005) 2.31
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta (2007) 2.31
Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department. Circulation (2010) 2.29
IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation (2011) 2.29
Sex differences in carotid endarterectomy outcomes: results from the Ontario Carotid Endarterectomy Registry. Stroke (2003) 2.28
Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures. CMAJ (2008) 2.23
The potential economic impact of restricted access to angiotensin-receptor blockers. CMAJ (2011) 2.22
Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors. CMAJ (2009) 2.16
Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol (2007) 2.15
Bundle branch block patterns and long-term outcomes in heart failure. Int J Cardiol (2010) 2.07
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05
Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients: a population-based cohort study. Diabetes Care (2013) 2.04
Prevalence and extent of obstructive coronary artery disease among patients undergoing elective coronary catheterization in New York State and Ontario. JAMA (2013) 2.03
Use of niacin in the United States and Canada. JAMA Intern Med (2013) 2.02
Long-term trends in use of and expenditures for cardiovascular medications in Canada. CMAJ (2009) 2.02
Association between weekend hospital presentation and stroke fatality. Neurology (2010) 2.00
Escalating levels of access to in-hospital care and stroke mortality. Stroke (2008) 1.97
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol (2012) 1.94
The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario. CMAJ (2003) 1.94
Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J (2008) 1.92
Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail (2012) 1.92
Self-reported use of mental health services versus administrative records: care to recall? Int J Methods Psychiatr Res (2004) 1.89
Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007. CMAJ (2010) 1.85
Use of ezetimibe in the United States and Canada. N Engl J Med (2008) 1.85
Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ Heart Fail (2010) 1.83
Temporal trends in the use of percutaneous coronary intervention and coronary artery bypass surgery in New York State and Ontario. Circulation (2010) 1.82
Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med (2012) 1.80
Regional differences in process of care and outcomes for older acute myocardial infarction patients in the United States and Ontario, Canada. Circulation (2006) 1.78
Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. Am Heart J (2010) 1.76
Geography and service supply do not explain socioeconomic gradients in angiography use after acute myocardial infarction. CMAJ (2003) 1.76
Impact of the choice of benchmark on the conclusions of hospital report cards. Am Heart J (2004) 1.72
Hospitalization rates and length of stay for cardiovascular conditions in Canada, 1994 to 1999. Can J Cardiol (2003) 1.71
Emergency department triage of acute myocardial infarction patients and the effect on outcomes. Ann Emerg Med (2009) 1.71
Inpatient smoking-cessation counseling and all-cause mortality in patients with acute myocardial infarction. Am Heart J (2007) 1.69
The identification and development of Canadian coronary artery bypass graft surgery quality indicators. J Thorac Cardiovasc Surg (2005) 1.68
The effect of a charted history of depression on emergency department triage and outcomes in patients with acute myocardial infarction. CMAJ (2011) 1.66
Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. Can J Cardiol (2011) 1.66
Population rates of cardiac catheterization and yield of high-risk coronary artery disease. CMAJ (2005) 1.64
Meta-analysis of the effects of endothelin receptor blockade on survival in experimental heart failure. J Card Fail (2003) 1.64
Statins and intracerebral hemorrhage: a retrospective cohort study. Arch Neurol (2011) 1.63
Time-related mortality for women after coronary artery bypass graft surgery: a population-based study. J Thorac Cardiovasc Surg (2004) 1.62
How many arterial grafts are enough? A population-based study of midterm outcomes. J Thorac Cardiovasc Surg (2006) 1.62
Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction. Eur Heart J (2006) 1.62
Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med (2010) 1.62
Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada. J Am Coll Cardiol (2003) 1.58
Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J (2007) 1.58
TPA use for stroke in the Registry of the Canadian Stroke Network. Can J Neurol Sci (2005) 1.58
Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol (2011) 1.58
Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care (2006) 1.57
Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol (2007) 1.56
Neighborhood income and stroke care and outcomes. Neurology (2012) 1.56
Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001. Can J Cardiol (2003) 1.56
Relationship between preventability of death after coronary artery bypass graft surgery and all-cause risk-adjusted mortality rates. Circulation (2008) 1.56
Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000. Am J Med (2004) 1.55
Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. Eur Heart J (2012) 1.53
Class effects of statins in elderly patients with congestive heart failure: a population-based analysis. Am Heart J (2007) 1.53
Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke (2008) 1.51
Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. CMAJ (2008) 1.51
Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study. BMC Med Res Methodol (2010) 1.50
Public versus private institutional performance reporting: what is mandatory for quality improvement? Am Heart J (2006) 1.50
Using methods from the data-mining and machine-learning literature for disease classification and prediction: a case study examining classification of heart failure subtypes. J Clin Epidemiol (2013) 1.50
Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol (2005) 1.48
Standardized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper. Can J Cardiol (2011) 1.47
Quality of care of international and Canadian medical graduates in acute myocardial infarction. Arch Intern Med (2005) 1.47
Gender differences in outcomes after hospital discharge from coronary artery bypass grafting. Circulation (2006) 1.46